Prometheus Laboratories is enrolling patients for Proclivity 01, a multi-center study of Proleukin (High Dose Interleukin-2 (HD IL-2)) combined with vemurafenib therapy in patients with Braf V600 mutation-positive metastatic melanoma (mM). ...
Tags: Prometheus, Proclivity 01 Study
San Carlos, California, United States of America (Free-Press-Release.com) May 7, 2013 -- Rosa & Co. LLC today announced that Dr. Michael A. Eldon, Principal Scientific Fellow, VP, Clinical Pharmacology, Nektar Therapeutics, will present a ...
Nimbus Discovery, a US-based biotechnology company, has entered into a co-development agreement with Shire aiming at small molecule treatments for lysosomal storage disorders (LSDs), which are considered as the rare genetic diseases. The ...
FOR IMMEDIATE RELEASE San Carlos, California, United States of America (Free-Press-Release.com) May 9, 2013 -- Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that ...
Tags: Construction, Decoration
Ablynx has commenced pre-clinical development of ALX-0962, an anti- immunoglobulin E (IgE) nanobody, to treat severe allergic asthma and expects to begin Phase I development in the second half of 2014. ALX-0962 comprises anti-IgE Nanobody ...
Tags: Ablynx, Pre-Clinical Development
Insulet Corporation and Eli Lilly and Company have entered into a collaboration under which Insulet will develop a new version of the OmniPod insulin pump designed to deliver Humulin R U-500 insulin. R U-500 insulin is a regular U-500 ...
Tags: Insulet, Eli Lilly, Insulin Pump
Diagnostic company LipoScience has begun the clinical development phase of a diagnostic test based on the gut flora metabolite, trimethylamine-N-oxide (TMAO). The nuclear magnetic resonance (NMR)-based TMAO assay is expected to detect ...
Tags: Liposcience, Clinical Development
Medical device company Topera has secured $25m in Series C financing round led by a new investor New Enterprise Associates (NEA). A new strategic industry partner and the company's existing investors and the management team have also ...
Tags: Topera, Series C Financing
Aptalis Pharma has deployed TransPerfect Trial Interactive as its global pharmacovigilance system master file (PSMF) technology. The Trial Interactive PSMF technology is compliant with the legal requirements as outlined in the Commission ...
Tags: Aptalis, Trial Interactive
Aeterna Zentaris has signed a co-development and profit sharing agreement with Ergomed Clinical Research for AEZS-108 in endometrial cancer. Ergomed has been selected as the contract clinical development organization to conduct the Phase ...
Perceptive Informatics, an eClinical solutions provider, has launched an enhanced version of its comprehensive Impact clinical trial management system (CTMS). The solution is used to plan, track and report on clinical trials and is ...
ReSearch Pharmaceutical Services (RPS), a US-based contract research organization (CRO) and Asklep, a Japanese CRO, have formed a new Joint Venture Company (JVC) to deliver R&D outsourcing solutions in Japan to the medical device and ...
Tags: Health, Medicine, Medical Device Industry
Boehringer Ingelheim and Eli Lilly and Company have announced the submission of new drug application (NDA) to FDA for an investigational type 2 diabetes mellitus (T2D) treatment, empagliflozin. Empagliflozin belongs to sodium glucose ...
Tags: diabetes therapy, drug application, drug
Biotechnology company bluebird bio has formed a broad collaboration with Celgene to develop new disease-altering gene therapies in oncology. The multi-year research and development collaboration aims to apply gene therapy technology to ...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Genzyme's oral Aubagio (teriflunomide) for relapsing-remitting multiple sclerosis (MS). Aubagio did not ...